Literature DB >> 28726171

QSAR modeling, docking and ADMET studies for exploration of potential anti-malarial compounds against Plasmodium falciparum.

Tabish Qidwai1.   

Abstract

Development of resistance in the Plasmodium falciparum to Artemisinin, the most effective anti-malarial compound, threatens malaria elimination tactics. To gain more efficacious Artemisinin derivatives, QSAR modeling and docking was performed. In the present study, 2D-QSAR model and molecular docking were used to evaluate the Artemisinin compounds and to reveal their binding modes and structural basis of inhibitory activity. Moreover, ADMET-related descriptors have been calculated to predict the pharmacokinetic properties of the effective compounds. The correlation expressed as coefficient of determination (r2) and prediction accuracy expressed in the form of cross-validated r2 (q2) of QSAR model are found 0.9687 and 0.9586, respectively. Total 239 descriptors have been included in the study as independent variables. The four chemical descriptors, namely radius of gyration, mominertia Z, SssNH count and SK Average have been found to be well correlated with anti-malarial activities. The model was statistically robust and has good predictive power which could be employed for virtual screening of proposed anti-malarial compounds. QSAR and docking results revealed that studied compounds exhibit good anti-malarial activities and binding affinities. The outcomes could be useful for the design and development of the potent inhibitors which after optimization can be potential therapeutics for malaria.

Entities:  

Keywords:  ADMET; Anti-malarial activity; Docking; Plasmodium falciparum; QSAR

Year:  2017        PMID: 28726171      PMCID: PMC5517390          DOI: 10.1007/s40203-017-0026-0

Source DB:  PubMed          Journal:  In Silico Pharmacol        ISSN: 2193-9616


  16 in total

Review 1.  Antimalarial drug discovery: efficacy models for compound screening.

Authors:  David A Fidock; Philip J Rosenthal; Simon L Croft; Reto Brun; Solomon Nwaka
Journal:  Nat Rev Drug Discov       Date:  2004-06       Impact factor: 84.694

2.  QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.

Authors:  Tabish Qidwai; Dharmendra K Yadav; Feroz Khan; Sangeeta Dhawan; R S Bhakuni
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  QSAR and docking based semi-synthesis and in vivo evaluation of artemisinin derivatives for antimalarial activity.

Authors:  Dharmendra Kumar Yadav; Sangeeta Dhawan; Akanksha Chauhan; Tabish Qidwai; Pooja Sharma; Rajendra Singh Bhakuni; Om Prakash Dhawan; Feroz Khan
Journal:  Curr Drug Targets       Date:  2014       Impact factor: 3.465

4.  Synthesis, antimalarial activity, biomimetic iron(II) chemistry, and in vivo metabolism of novel, potent C-10-phenoxy derivatives of dihydroartemisinin.

Authors:  P M O'Neill; A Miller; L P Bishop; S Hindley; J L Maggs; S A Ward; S M Roberts; F Scheinmann; A V Stachulski; G H Posner; B K Park
Journal:  J Med Chem       Date:  2001-01-04       Impact factor: 7.446

Review 5.  Current perspectives on the mechanism of action of artemisinins.

Authors:  Jacob Golenser; Judith H Waknine; Miriam Krugliak; Nicholas H Hunt; Georges E Grau
Journal:  Int J Parasitol       Date:  2006-09-12       Impact factor: 3.981

6.  admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties.

Authors:  Feixiong Cheng; Weihua Li; Yadi Zhou; Jie Shen; Zengrui Wu; Guixia Liu; Philip W Lee; Yun Tang
Journal:  J Chem Inf Model       Date:  2012-11-01       Impact factor: 4.956

7.  Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria.

Authors:  Mitchell A Avery; Kannoth M Muraleedharan; Prashant V Desai; Achintya K Bandyopadhyaya; Marise M Furtado; Babu L Tekwani
Journal:  J Med Chem       Date:  2003-09-25       Impact factor: 7.446

8.  Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family.

Authors:  G H Posner; M H Parker; J Northrop; J S Elias; P Ploypradith; S Xie; T A Shapiro
Journal:  J Med Chem       Date:  1999-01-28       Impact factor: 7.446

Review 9.  Falcipain-2 inhibitors.

Authors:  Roberta Ettari; Floriana Bova; Maria Zappalà; Silvana Grasso; Nicola Micale
Journal:  Med Res Rev       Date:  2010-01       Impact factor: 12.944

10.  Synthesis and antimalarial activity of novel dihydro-artemisinin derivatives.

Authors:  Yang Liu; Kunqiang Cui; Weiqiang Lu; Wei Luo; Jian Wang; Jin Huang; Chun Guo
Journal:  Molecules       Date:  2011-05-30       Impact factor: 4.411

View more
  4 in total

1.  Computational prediction of small molecules with predicted binding to FGFR3 and testing biological effects in bone cells.

Authors:  Subburaman Mohan; Karthikeyan Muthusamy; Selvaraman Nagamani; Chandrasekhar Kesavan
Journal:  Exp Biol Med (Maywood)       Date:  2021-03-27

2.  In silico ADME and Toxicity Prediction of Ceftazidime and Its Impurities.

Authors:  Ying Han; Jingpu Zhang; Chang Qin Hu; Xia Zhang; Bufang Ma; Peipei Zhang
Journal:  Front Pharmacol       Date:  2019-04-24       Impact factor: 5.810

3.  A Rapid Assessment Model for Liver Toxicity of Macrolides and an Integrative Evaluation for Azithromycin Impurities.

Authors:  Miao-Qing Zhang; Jing-Pu Zhang; Chang-Qin Hu
Journal:  Front Pharmacol       Date:  2022-04-04       Impact factor: 5.988

4.  Molecular Docking, Validation, Dynamics Simulations, and Pharmacokinetic Prediction of Phytochemicals Isolated From Croton dichogamus Against the HIV-1 Reverse Transcriptase.

Authors:  Ermias Mergia Terefe; Arabinda Ghosh
Journal:  Bioinform Biol Insights       Date:  2022-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.